euglena Co (FRA:8EG) Short-term investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8EG euglena Co Ltd FRA:8EG
63 GF Score
Price €1.91
GF Value €2.47
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is euglena Co Short-term investments?

Short-term investments only applies to insurance companies.

FRA:8EG
63GF Score
euglena Co Ltd FRA:8EG
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is euglena Co (FRA:8EG) Overvalued in 2026?

Based on GuruFocus' analysis, euglena Co stock appears to be undervalued. The current stock price of €1.91 is trading 22.7% below its estimated GF Value™ of €2.47. GuruFocus considers euglena Co to be Modestly Undervalued.

Key valuation signals for FRA:8EG:

  • Short-term investments:
  • GF Value™: €2.47 vs. price of €1.91 (22.7% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the FRA:8EG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

euglena Co Business Description

Other Exchanges 2931:Japan
Address 5-29-11 Shiba, Minato-ku, Tokyo, JPN
euglena Co., Ltd. is a Japanese biotechnology company centered on the commercial cultivation and application of microalgae, particularly euglena and chlorella. Its Healthcare segment produces and sells functional foods, supplements, and cosmetics, including the euglena-based green juice and chlorella products that generate most of its revenue, sold mainly in Japan through direct-to-consumer channels and retail. The company also pursues biofuels and sustainability-related businesses, developing microalgae-derived fuels and researching carbon capture and utilization, alongside other ventures such as a bioinformatics subsidiary and overseas operations. Its customers include individual consumers of health and beauty products, as well as corporate and research partners in energy and environmental fields. Revenue comes primarily from product sales, with growing contributions from biofuel and other businesses.
63GF Score

Get the complete analysis for FRA:8EG

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.91
Price
€2.47
GF Value